Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (101-110 of 195) with videos related to

Pageof 20
Sort By:
Internal Medicine Journal|January 30, 2004
Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosisA Grigg, N J Tubridy, J Szer, et al.
American Journal of Hematology|May 1, 1995
Application of interphase cytogenetics to monitor bone marrow transplantsV Vrazas, L M Ooms, C Rudduck, et al.
Bone Marrow Transplantation|March 29, 2000
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovirC B Steer, J Szer, J Sasadeusz, et al.
Transfusion|June 1, 1991
Factors influencing 20-hour increments after platelet transfusionJ F Bishop, J P Matthews, K McGrath, et al.
Pathology|October 14, 1998
Guidelines for the collection, processing, storage and of administration of hemopoietic stem and progenitor cells for transplantation. Report of the Working Party on Hemopoietic Stem Cell Processing, Hematology Discipline Advisory Committee, the Royal College of Pathologists of AustralasiaL B To, K M Shepherd, R Lam-Po-Tang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 1999
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantationP R Ebeling, D M Thomas, B Erbas, et al.
Clinical and Laboratory Haematology|March 19, 2003
Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemiaC McNamara, A Grigg, J Szer, et al.
British Journal of Haematology|March 1, 1988
Transient platelet and HLA antibody formation in multitransfused patients with malignancyK McGrath, M Wolf, J Bishop, et al.
Internal Medicine Journal|July 24, 2004
Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcomaD S Ritchie, A P Grigg, A W Roberts, et al.
Bone Marrow Transplantation|May 24, 2016
All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New ZealandP Kruger, J Cooney, I Nivison-Smith, et al.
Pageof 20

Showing results (101-110 of 195) with videos related to

Sort By:
Pageof 20
Internal Medicine Journal|January 30, 2004
Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosisA Grigg, N J Tubridy, J Szer, et al.
American Journal of Hematology|May 1, 1995
Application of interphase cytogenetics to monitor bone marrow transplantsV Vrazas, L M Ooms, C Rudduck, et al.
Bone Marrow Transplantation|March 29, 2000
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovirC B Steer, J Szer, J Sasadeusz, et al.
Transfusion|June 1, 1991
Factors influencing 20-hour increments after platelet transfusionJ F Bishop, J P Matthews, K McGrath, et al.
Pathology|October 14, 1998
Guidelines for the collection, processing, storage and of administration of hemopoietic stem and progenitor cells for transplantation. Report of the Working Party on Hemopoietic Stem Cell Processing, Hematology Discipline Advisory Committee, the Royal College of Pathologists of AustralasiaL B To, K M Shepherd, R Lam-Po-Tang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 23, 1999
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantationP R Ebeling, D M Thomas, B Erbas, et al.
Clinical and Laboratory Haematology|March 19, 2003
Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemiaC McNamara, A Grigg, J Szer, et al.
British Journal of Haematology|March 1, 1988
Transient platelet and HLA antibody formation in multitransfused patients with malignancyK McGrath, M Wolf, J Bishop, et al.
Internal Medicine Journal|July 24, 2004
Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcomaD S Ritchie, A P Grigg, A W Roberts, et al.
Bone Marrow Transplantation|May 24, 2016
All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New ZealandP Kruger, J Cooney, I Nivison-Smith, et al.
Pageof 20